The global lymphoma treatment market is predicted to surge in value from USD 8.08 billion in 2025 to USD 16.62 billion by 2034, expanding at a compelling CAGR of 8.34% over the forecast period, as breakthrough therapies and AI-driven innovation shift cancer care to new heights. Fueled by the demand for precision treatments and technological advances, […]
RNA Editing for Neurodegenerative Diseases Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Eli Lilly & Co. GSK Plc Korro Bio Moderna Inc. ProQR Therapeutics Roche Holding AG Shape Therapeutics Takeda Pharmaceutical Company Verve Therapeutics Wave Life Sciences Regeneron Pharmaceuticals Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. – San
AI-Driven Drug Discovery Platforms Market Companies Atomwise BenevolentAI Cloud Pharmaceuticals DeepMind (Alphabet) Exscientia Healx Insilico Medicine LabGenius Numerate Owkin Recursion Pharmaceuticals Relay Therapeutics Schrödinger Valo Health twoXa Download Sample Report Atomwise Company Name and Headquarters: Atomwise Inc., San Francisco, CA, USA Product Offerings: AtomNet® platform, an AI-powered drug discovery platform that uses deep convolutional neural networks to
Rare Musculoskeletal Disorder Treatments Market Companies Astellas Amgen AstraZeneca BioMarin Pharmaceutical Eli Lilly Fujifilm/possible CDMOs (manufacturing partners) Ionis Pharmaceuticals Novartis Pfizer PTC Therapeutics Regenxbio Sarepta Therapeutics Sanofi Takeda Cytokinetics Download Sample Report Astellas Pharma Inc. Headquarters: Tokyo, Japan Product Offerings related to Rare Musculoskeletal Disorder Treatments: While Astellas is a major pharmaceutical company with a broad portfolio,
RNA Editing Therapies Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Catalent GSK Korro Bio Moderna ProQR Therapeutics Regenxbio Roche Shape Therapeutics Wave Life Sciences ADAPTABLE CDMO / specialized oligo CDMOs Smaller specialist startups & platform players Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. (San Diego, California, USA) Product
The rare disease small-batch CDMO market is projected to experience significant growth through 2034, driven by the increasing prevalence of rare diseases and the rising approvals of orphan drugs. With an expected compound annual growth rate (CAGR) propelled by advancements in precision medicine and specialized manufacturing, this market is becoming a critical partner for biopharma
LNP CDMO Market Companies Lonza Group WuXi AppTec Samsung Biologics Catalent Moderna Evonik Industries CordenPharma BioNTech Albemarle Corporation Kuehne + Nagel Northway Biotechpharma Cryoport, Inc. AMRI Pharmaron Genevant Sciences Miltenyi Biotec SynBioTech JHL Biotech Particle Sciences, Inc. Acell Technologie Download Sample Report Lonza Group Company Name and Headquarters: Lonza Group AG, Basel, Switzerland Product Offerings related
Biomarker Discovery Outsourcing Services Market Companies Eurofins Scientific Charles River Laboratories ICON plc Labcorp Drug Development Thermo Fisher Scientific WuXi AppTec Syneos Health Q² Solutions (IQVIA & Quest Diagnostics JV) Bio-Rad Laboratories PPD Inc. (Thermo Fisher Scientific) SGS SA Evotec SE Creative Biolabs GenScript Biotech Corporation DiscoverX (Eurofins Discovery) Proteome Sciences plc Medpace Holdings, Inc.
The global metabolomics market is poised for explosive growth, projected to surge from USD 4.31 billion in 2025 to an impressive USD 14.40 billion by 2034. This expansion reflects a robust CAGR of 14.34% over the forecast period, underscored by rising investments in precision medicine, biomarker discovery, and pharmaceutical R&D. North America currently leads the market, while Asia Pacific
The ovine and caprine artificial insemination market reached USD 1.25 billion in 2024 and will increase to USD 1.33 billion in 2025, eventually hitting USD 2.31 billion by 2034. Expansion is fueled by rising demand for genetic improvement, sustainable livestock management, dairy innovation, and the growing influence of artificial intelligence in precision breeding. Ovine And
